FamiOne, Inc.

FamiOne, Inc. is a Japan-based company dedicated to providing comprehensive support for individuals and couples navigating fertility challenges through innovative healthcare consultations and resources. Founded in 2015 and headquartered in Tokyo, Japan, FamiOne, Inc. specializes in fertility support services.

The company has successfully completed four deals, with its latest funding round being a Series A amounting to JPY 133. 000 mn, raised from Canal Ventures and Sumitomo Life Insurance, bringing the total amount raised to JPY 133. 000 mn and a current valuation of JPY 1185. 412 mn.

The leadership includes CEOs Koji Akutsu and Yusuke Ishikawa. FamiOne, Inc. offers a suite of services aimed at supporting individuals and couples in their fertility journey. The core offerings include healthcare consultation services, which provide access to a network of approximately 50 specialists who assist clients with health-related challenges related to fertility.

The platform allows for anonymous consultations via LINE, catering to a diverse audience that includes individuals experiencing difficulties with conception and couples seeking guidance to prevent relationship strains associated with fertility issues. FamiOne’s services are operational in various regions, including Yokohama, Hiroshima, and Nagasaki, where they participate in government-supported initiatives such as the "Yokohama Fertility SNS Consultation Project" and the "Health LINE Support Project. " These programs aim to deliver tailored support and expert advice to enhance the fertility experience for users. FamiOne generates revenue through subscription-based models and partnerships with municipal programs aimed at health and wellness support.

Clients typically engage with FamiOne's services via healthcare consultations, which may include flagship offerings such as specialized health kits designed to assess reproductive health, such as the “F Check Ovarian Age Check Kit” and the “Uterine Microflora Check Kit. ” Pricing plans are structured to facilitate both individual access and corporate wellness programs, allowing businesses to integrate these services as part of employee benefits. Revenue streams are bolstered by collaborations with local governments, ensuring a steady flow of clients seeking fertility support and health education through these established channels. In September 2024, FamiOne, Inc.

raised an undisclosed amount of venture funding from new investors Future Venture Capital and SBI Investment. The investment aims to enhance healthcare support services, expand collaboration with partners, and provide better support for employees and community residents. The company is focused on developing new products that will further assist clients in their fertility journeys while planning to expand its services to additional regions in Japan by the end of 2025.